News/ News/ Sales and Marketing AbbVie files Qulipta for chronic migraine prevention Phil Taylor AbbVie, Biohaven Pharmaceuticals, migraine, Nurtec ODT, Pfizer, prevention, Qulipta 0 Comment AbbVie has filed for approval of its oral CGRP inhibitor Qulipta for prevention of chronic migraine, seeking to Share X AbbVie files Qulipta for chronic migraine prevention https://pharmaphorum.com/news/abbvie-files-qulipta-for-chronic-migraine-prevention/